Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Randomized Trial of Radiation Therapy in Oligometastatic mCRPC Prostate Cancer (ARTO) (NCT03449719) | Lorenzo Livi | 2018-05-01 |
Track Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone automatically
Every clearance here is in the API, with alerts when new ones post.